ムラト・サヴァシュ教授は、ベルリンのシャリテ病院にて腹腔鏡手術の専門研修を受け、30年の経験年にわたる泌尿器科の専門知識を有しています。
Prof. Montorsi is one of the top Italian experts in Urology and Andrology, with numerous scientific awards and 8,000+ urology/andrology surgeries. He directs the Urological Research Institute (URI) in Italy, is recognized among the most influential researchers of the past decade, and has developed his vein patching method to correct occlusive vein dysfunction. He is an Honorary Fellow of the Royal College of Surgeons of England and has written over 1,000 papers. He is a member of various medical organizations.
Accepting patients in the Urology medical unit of Florya Hospital, Prof. Dr. Semih Ayan completed his education at Sivas Cumhuriyet University Faculty of Medicine in 1997 and received the title of Urology Specialist. In 1999, he became a Postdoctoral Fellow in Pediatric Urology at Harvard University; He became Associate Professor of Urology in 2003 and Professor of Urology in 2009. In 2015, he completed his Minimal Invasive Urological Oncology (Clinical Fellow) studies at the University of Chicago and crowned his professional education and experience with international studies.
In the field of Urological Oncology, which is one of the physician's areas of interest, surgical treatment of prostate cancer, bladder cancer and kidney tumors provides a significant increase in the survival rate and the chance of surviving cancer. In the field of Pediatric Urology, which is another area of interest, congenital anomalies such as renal outflow stenosis, urinary reflux to the kidney and hypospadias are corrected by using innovative surgical applications and a lifelong contribution is provided to the patients.
Medical equipment required for medical diagnosis, treatment and surgical treatment to be given in the areas specified in our urology units, laparoscopic surgeries and all kinds of equipment suitable for the use of new surgical techniques are available in our hospital. With the treatment and operations performed in our hospitals by making use of the best facilities offered by medical technology, a significant increase in the quality of life is achieved while the patients are healed.
prof. Dr. Semih Ayan received almost all of his medical education and certificates from the leading institutions of America and Europe, and gained deep knowledge and international experience in many advanced specialties of urology. prof. Dr. Among the trainings and certificates Ayan has received internationally;
American Medical License (USML)
Pediatric Urology Fellow (1999-2000/Boston, USA)
Urological Oncology Fellow (2014-2015/USA).
Dr. Ofer Yossefovitz is a leading Israeli urological surgeon. He specializes in oncological, laparoscopic, and robotic urology. He has over 25 years of clinical experience. Dr. Yossefovitz earned his MD at Jerusalem University. He also completed advanced fellowships at Memorial Sloan Kettering Cancer Center in the USA.
Dr. Yossefovitz has led oncological urology departments at Ichilov and Beilinson hospitals. He has published many scientific papers. He is also a Senior Lecturer at Tel Aviv University. Dr. Yossefovitz is a member of the Israeli, European, and American Urology Associations. His memberships reflect his international accreditation and recognition.
Dr. Ramazan Altin is a urologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (English) in 2000. He completed his urology specialization there in 2005.
He advanced his expertise in uro-oncology and robotic surgery in 2013 at Yıldırım Beyazıt University, Ankara Atatürk Training and Research Hospital. He continued this training in 2014 at the Cleveland Clinic Glickman Urological and Kidney Institute.
He has worked at Medicana Ataköy Hospital (2023–2024), İstinye University Bahçeşehir Liv Hospital (2017–2020), and İnönü University Turgut Özal Medical Center (2011–2017). He also has experience in state, private, and military hospitals.
Dr. Suebpong Angchoun (Dr. Beer) is a urologist and men’s health specialist. He is the founder and medical director of Eternity Clinic. His work focuses on minimally invasive surgery and male sexual health. He also serves as director of the Urology Center at Bangkok Hospital Phuket.
Education/Accreditations: M.D. (2003), Prince of Songkla University. Diploma, Thai Board of General Surgery (2008). Diploma, Thai Board of Urology (2011), Prince of Songkla University.
Clinical focus: erectile dysfunction, testosterone replacement therapy, endoscopic urology (minimally invasive), kidney stones, and prostate health.
Eduardo Fernandez, MD
Medical Doctor & Stem Cell Expert
Dr. Eduardo Fernandez is a distinguished medical professional specializing in stem cell therapies and regenerative medicine. He is a certified member of the Mexican College of Stem Cells and Regenerative Medicine, as well as the Mexican Council of Stem Cells for Therapeutic and Research Purposes. Dr. Fernandez’s certifications are the result of a rigorous 8-hour examination process, reserved for a select group of doctors who possess advanced knowledge and experience in these cutting-edge treatments. With only 50 certified doctors in Mexico, Dr. Fernandez’s expertise is highly sought after and respected.
In addition to his national recognition, Dr. Fernandez is awaiting international certification from the renowned International Society for Stem Cell Research (ISSCR). Membership in this prestigious organization signifies Dr. Fernandez’s extensive experience and expertise in stem cell treatments. The ISSCR includes prominent scientists from renowned universities such as Harvard, Yale, Stanford, and other esteemed institutions worldwide. Being a part of this elite society represents the pinnacle of honor and prestige in the field of stem cell therapies.
Furthermore, Dr. Fernandez is also seeking membership and international certification from the International Society for Extracellular Vesicles (ISEV), the largest community of extracellular vesicle researchers globally. With only two thousand members worldwide, ISEV’s select nature underscores Dr. Fernandez’s exceptional dedication to advancing scientific knowledge in the study of exosomes and cellular messengers. By pursuing membership in ISEV, Dr. Fernandez continues to demonstrate his commitment to staying at the forefront of research and innovation in the field of regenerative medicine.
Specialties
Kidney and urinary tract endoscopic stone crushing treatment
Endoscopic Prostate and Bladder Surgery (TUR Method)
Diagnosis and surgery of testicular diseases
Diagnosis and treatment of infertility in men (Varicocele surgeries)
Diagnosis and treatment of sexual dysfunctions
Treatment of urinary incontinence in women
Treatment of nocturnal incontinence in children
Treatment of undescended testicle in children
Circumcision
Experience
1995-1999 Bilecik State Hospital Urology Clinic
1999-2002 Kocaeli Gölcük State Hospital Urology Clinic
2002-2006 Sakarya Karasu State Hospital Urology Clinic and Chief Physician
2006-2012 Kocaeli State Hospital Urology Clinic and Chief Physician
2012-2015 Kocaeli State Hospital Urology Clinic
2015-2018 Kocaeli Public Hospitals Secretary General
2018-2021 Kocaeli Provincial Health Director
2021-2023 Kocaeli Darıca Farabi Training and Research Hospital Urology Clinic
2023- 2024 Kocaeli Gölcük Necati Çelik State Hospital Urology Clinic
2024 Private Darıca Büyük Anadolu Hospital
Education
Uludag University Faculty of Medicine (graduation) 1988
Selcuk University Faculty of Medicine (specialization) 1994
1982-1988 Uludağ University Faculty of Medicine
1990 -1994 Selcuk University Faculty of Medicine, Department of Urology (Specialization)
Scientific Publications
Acar A., Sert I. Ü., Gürbüz R., Ergüney Ş: Submucosal methotrexate applications in inoperable bladder tumors. S.Ü.T.F. Journal. 1993; 9(1):39-41
Acar A., Sert İ.Ü., Gürbüz R., Arslan E.M., Ergüney Ş. , : Bladder wall and prostate
Translated with DeepL.com (free version)
Head of Teaching at the Puerto Vallarta Regional Hospital
2020-2023
Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020
General practitioner in private medical office
2015-2022
Doctor in charge of weight control clinic
2013-2014
Medical assistant in dermatology clinic
2008-2013
Medical Assistant in Dermatological procedures.
Medical Assistant in minimally invasive surgical procedures
Operation of fractional laser machine - IPIXEL-ER and
facial rejuvenation with IPL.
Experience in laser hair removal with Intense Pulsed Light and
radiofrequency
Experience with ultrasonic cavitation
Experience with ultraviolet (UV) light phototherapy machine for the
treatment of psoriasis and vitiligo.
Experience assisting in Botox and Fillers procedures.
Biomagnet certified by the Higher Institute of Biomagnetism
doctor ISAAC GOIZ DURAN
Experience in clinical records
Training in continuing education and professional development of teachers
Dr. Thanaphat Pomyukon is a general surgeon (ศัลยแพทย์ทั่วไป). Thai medical license no. ว.50550. He earned his M.D. from the Faculty of Medicine, Chulalongkorn University. He also holds the Thai Board Diploma in General Surgery from Roi Et Hospital, Ministry of Public Health.
His clinical focus includes hernias and hemorrhoids. He also treats breast lumps and gallstones. He manages digestive system diseases. He performs gastrointestinal endoscopy, including gastroscopy and colonoscopy.
Languages: Thai (primary) and English (professional clinical level).
Academic degree, name, and surname: Assoc. Prof. Dr. Bahadır Topuz Activity direction: Urology Medical areas of interest: Laser Prostate Enucleation Surgery (HoLEP, ThuFLEP) Rezum (Water Vapor to Prostate) Surgery Urooncology Robotic and Laparoscopic Surgery Andrology Penile Prosthesis Surgeries Infertility Pediatric Urology Education: Primary School – Güventürk Primary School, Kayseri, Türkiye (1989-1994) Secondary School – Gözübüyük Secondary School, Kayseri, Türkiye (1994-1997) High School – Melikgazi Super High School, Kayseri, Türkiye (1997-2001) University – GATA, Gülhane Military Medical Faculty, Ankara, Türkiye (2001-2007) Specialization – GATA Urology department, Ankara, Türkiye (2010-2015) Experience: 2007-2008: General Practitioner, GATA Intern and Course Company, Etlik, Ankara, Türkiye 2008-2010: General Practitioner, 3rd Armored Brigade Infantry Battalion, Çerkezköy, Tekirdağ, Türkiye 2010-2015: Urology Specialization Student, GATA Urology Department, Etlik, Ankara, Türkiye 2015-2016: Urology Specialist, GATA Urology Department, Etlik, Ankara, Türkiye 2016-2022: Urology Specialist, Gülhane Training and Research Hospital, Department of Urology, Etlik, Ankara, Türkiye 2022-2023: Associate Professor Doctor, Urology Specialist, Gülhane Training and Research Hospital, Department of Urology, Etlik, Ankara, Türkiye 2023-Present: Private Urology Center, Şişli, Istanbul, Türkiye and Liv Bona Dea Hospital, Baku, Azerbaijan
Dr. Sılay is an experienced pediatric urologist practicing in Turkey.
Assoc. Prof. Selçuk Sılay specializes in robotic surgery for urology conditions in children.
Dr. Selçuk Sılay has provided over:
Prof. Selçuk Sılay provides research in robotic surgery in children. Has written over 80 articles.
Education:
1997 – 2003 Hacettepe University
2004 – 2009 Ankara Dışkapı Training and Research Hospital
2016 – 2019 Afyon Kocatepe University
Experience:
2022 – Still Lokman Hekim Akay Hospital
2019 – 2022 Private Meddem Hospital
2018 – 2019 Afyon Kocatepe University
2015 – 2018 Afyon Kocatepe University
2012 – 2015 Bozok University Faculty of Medicine
2010 – 2012 Ankara Dışkapı Training and Research Hospital
2009 – 2010 TSK Rehabilitation and Care Center Presidency
2004 – 2009 Ankara Dışkapı Training and Research Hospital
Education/Academic Experience
Apr 1995 – Oct 2001 Medical School of Aristotle University of Thessaloniki, Greece
Mar 2007 IELTS Certificate (Overall Band Score 7.5)
Feb 2011 CCST in Urology, Aristotle University of Thessaloniki, Greece
June 2012 Fellow of the European Board of Urology (FEBU)
Sept 2014 Fellow in Andrology/Reconstructive Surgery (Mr Giulio Garaffa, UCLH / Mid-Essex)
Apr 2016 Fellow of the Royal College of Surgeons of England (FRCS Eng)
Oct 2018 Honorary Senior Lecturer St Andrews University
Sep 2019 Urology ChM Tutor in Andrology and Minimally Invasive Surgery (MIMS) University of Edinburgh
Aug 2020 European Union Expert Panel Member of in vitro Medical Devices (EU EXPAMED)
Current and Previous appointments
Current appointment
May 2022- Present Consultant Urologist German Oncology Centre, Limassol, Cyprus
Previous appointments
Nov16- May 2021 Consultant Urological Surgeon Victoria/ Queen Margaret Hospital Fife, Scotland.
Nov 2012 - Oct 2016 Consultant Urologist Broomfield Hospital, Mid-Essex Hospitals Trust
Jan 2011 - Oct 2012 Urology Clinical Research Fellow, Spelialist Registrar Level), Bristol Royal Infirmary, United Bristol Hospitals Trust
Dec 2009 -Dec 2010 Urology Resident G. Gennimatas Hospital, Aristotle University of Thessaloniki
Duties
Consultant Urologist providing and supervising the services of andrology and urethral reconstruction surgery. Also covering a general urology one stop outpatient clinics three times per week (Victoria and Queen Margaret Hospitals).
Participation in once weekly local cancer and once monthly specialist male uro-genital reconstruction MDT meetings (Honorary contract at the Western General Hospital, Edinburgh) as well as grand ward rounds.
Undergraduate student trainer and member of examiners panel at St Andrews University, Scotland.
Participation in 1:9 on call Urology Consultant rota.
Research
Teaching Experience
Fife Simulation BPH Course Fascilitator (Scottish Urology Training Programme, Queen Margaret Hospital, Dumfermline Fife)
Urology Simulation boot camp Faculty member (St James's University Hospital, Leeds)
General Practitioner Urology Training Programme Fascilitator (ScotGem)
Objective Structured Clinical Examination (OSCE) assessor (St Andrews University Medical School)
Teaching (case-based discussions) and trainee supervision in theatres (East Anglia / East of Scotland Deaneries trainees)
FY1 Doctors Urology teaching Bristol Royal Infirmary (University Bristol Hospitals Trust)
Undergraduate teaching of medical students in General Hospital of the city of Drama, Greece
Anatomy, Physiology and First Aid to Undergraduate nursing students
Dr. Bugra Bilge Keseroglu specializes in robotic and laparoscopic urology. His robotic work includes radical prostatectomy (conventional and Retzius-sparing), radical cystectomy, sacrocolpopexy, and Burch colposuspension. His laparoscopic work includes radical prostatectomy with lymph node dissection, radical cystectomy, sacrocolpopexy, and Burch colposuspension. He also performs laparoscopic nephrectomy and partial nephrectomy, pyeloplasty, all endourological surgeries (stone surgery and endoscopic procedures), HOLEP, and female incontinence surgery.
Education: Uludağ University Faculty of Medicine, 1990–1996. Specialization: S.B. Ankara Training and Research Hospital, 1997–2002. Experience: Yozgat State Hospital, 2002–2006 and 2012–2016; Yozgat Private Hospital, 2006–2011; S.B. Ankara Training and Research Hospital, 2016–2019; Bilkent City Hospital, 2019–2024.
Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.
Academic degree, name and surname: Assoc.Prof.Dr.Murat Zor Activity direction: Urology Medical areas of interest: Urooncology Robotic Urology and Endourology Laser Technologies and Laser Prostate Surgeries (HoLEP, ThuFLEP) MRI Transrectal/Transperineal Ultrasonography Prostate Fusion Biopsy Endoscopic Stone Surgery Education: Gülhane Military Medical Academy Experience: Liv Ulus Hospital Kolan International Hospital Gülhane Training and Research Hospital Gülhane Military Medical Faculty University of Health Sciences, Gülhane Faculty of Medicine Memberships: Turkish Association of Urology Endourological Association European Association of Urology (EAU) American Urological Association (AUA) Endourological Society Awards: Turkish
Dr. Ayan graduated from Medical School in 1991 and completed his urology education in 1997. At the beginning of his carrier, he was a post doctorate research fellow at the Department of Urology of Harvard Medical School, Children’s Hospital in Boston (1999-2000). He studied the effect of partial ureteral obstruction to the kidney in early developmental stage in an experimental animal fetus model. This study provided a significant contribution to a complicated issue of pediatric urology and was cited many times by its successors.
He became associate professor of urology in 2004 and was appointed as a professor of urology in 2009. He was accepted as a clinical fellow in Minimal Invasive Urologic Oncology at the Department of Surgery, Section of Urology at the University of Chicago (2014-2015). He worked in an intense oncology program mainly concentrated on robotic surgery of prostate and kidney cancer. Because of this background, he is mainly interested in urologic oncology and pediatric urology. The primary portion of his daily practice consist of kidney cancer, prostate cancer, bladder cancer, neonatal hydronephrosis, ureteropelvic junction obstruction, urine reflux to kidney, hypospadias and undescended testis.
Because of its prevalence in Turkey, Prof. Ayan has a huge experience with urinary stone disease and he is doing large number of endoscopic and percutaneous surgeries for kidney, ureter and bladder stones.
Prof. Ayan holds United States Medical License and European Board of Urology Certificate. He is a member of AUA, EAU and Turkish Urologic Surgery and Urologic Oncology Societies.
List of International Scientific Publications;
1. Ayan S, Yildirim S, Ucar C, Sarioglu Y, Gültekin EY, Butuner C. Corporal reactivity to adenosine and prostaglandin E1 in alloxan-induced diabetic rabbit corpus cavernosum and the effect of insulin therapy. BJU Int, 83: 108-12, 1999.
2. Yildirim S, Ayan S, Sarioglu Y, Gültekin EY, Butuner C. The effects of long-term oral administration of L-arginine on the erectile response of rabbits with alloxan-induced diabetes. BJU Int, 83: 679-85, 1999.
3. Ayan S, Kaloglu C, Gökce G, Kılıcarslan H, Gültekin EY. Effect of insulin therapy to diabetic cystopathy: urodynamic and histological findings in a rabbit model. Sc J Urol Nephrol, 33: 392-5, 1999.
4. Yildirim S, Ayan S, Sarioglu Y, Gültekin Y, Uma S. Does diabetes mellitus affect the progress of tolerance to isosorbide dinitrate (ISDN) in corporal tissue? Nitric Oxide: Biology and Chemistry, 4: 29- 34, 2000.
5. Ayan S, Sarioglu Y, Yildirim S, Gokce G, Bagcıvan I. Relaxation induced by omeprazole does not change in diabetic rabbit corpus cavernosum. BJU Int, 87(3):265-8, 2001.
6. Ayan S, Gokce G, Kılıcarslan H, Kaya K, Gultekin EY. An unusual cause of urinary incon tinence: urethral coitus. Sc J Urol Nephrol, 35:254, 2001.
7. Yildirim S, Simsek R, Ayan S, Gokce G, Sarıoğlu Y, Safak C. Relaxant effect of some benzothiazolinone dervatives on isolated rabbit corpus cavernosum. Urol Res, 29:182-5, 2001.
8. Ayan S, Roth JA, Freeman MR, Bride SH, Peters C. Partial ureteral obstruction dysregulates the RAS in the fetal sheep. Urology, 58: 301-6, 2001.
9. Kılıcarslan H, Ayan S, Gokce G, Kaya K, Gultekin EY. Cranial blind ending branch of a bifid ureter. Int Urol Nephrol, 32: 635-6, 2001.
10. Gokce G, Kılıcarslan H, Ayan S, Yıldız E, Kaya K, Gultekin EY. Adenomatoid tumors of testis and epididym: a report of two cases. Int Urol Nephrol, 32:677-80, 2001.
11. Ayan S, Gokce G, Kılıcarslan H, Ozdemir O, Yildiz E, Gultekin EY. K-RAS mutation in transitional cell carcinoma of urinary bladder. Int Urol Nephrol, 33:363-67, 2001.
12. Bulut HE, Onarlıoglu B, Kaloglu C, Özdemir Ö, Ayan S. Effects of experimental diabetes and insulin treatment on rabbit renal morphology: a quantitative and qualitative study. Turk J Med Sci, 31: 209-16, 2001.
13. Kılıcarslan H, Gokce G, Ayan S, Gultekin EY, Arıkan Y, Hocaoglu S. Fournier’s gangrene: a report of 20 cases. T Klin J Med Res 19:55-58, 2001.
14. Gokce G, Kılıcarslan H, Ayan S, Tas F, Akar R, Kaya K, Gultekin EY. Genitourinary tuberculosis: A review of 174 cases. Scand J Infect Dis, 34: 338-40, 2002.
15. Kilicarslan H, Yildirim S, Bagcivan I, Ayan S, Sarac B, Sarioglu Y. Effect of chronic renal failure (CRF) on purinergic responses of corpus cavernosal smooth muscle in rabbits. BJU Int 90(6):596-600, 2002.
16. Bagcivan I, Gokce G, Ayan S, Yildirim S, Sarac B, Kilicarslan H, Sarioglu Y. Hydrogen-potassium ATPase inhibitors induce relaxation on rabbit prostatic strips in vitro.Int J Urol.;9(11):641-4; discussion 645, 2002.
17. Bagcivan I, Kilicarslan H, Sarac B, Gokce G, Yildirim S, Ayan S, Sarioglu Y. The evaluation of the effects of renal failure on erectile dysfunction in a chronic renal failure (CRF) rabbit model. BJU Int.;91(7):697-701, 2003
18. Kilicarslan H, Guvenal T, Ayan S, Gokce G, Cetin A, Gultekin Y. Comparison of outcomes of three different surgical techniques performed for stress urinary incontinence. Int J Urol.;10(3):126- 30, 2003.
19. Kaya S, Poyraz O, Gökçe G, Kılıçarslan H, Kaya K and Ayan S. Role of Genital Mycoplasmata and Other Bacteria in Urolithiasis. Scand J Infect Dis, 35:315-317,2003.
20. Kilicarslan H, Gokce G, Ayan S, Atalar M, Kaya S, Kaya K, Gultekin Y. A case of hydatid disease: urinary retention due to isolated retrovesical hydatid cyst in a boy. Scand J Infect Dis, 35 :408-410, 2003.
21. Gokce G, Kaya K, Kılıcarslan H, Tas F, Ayan S, Yıldız E, Gultekin E Y. Epidermoid cyst in the renal pelvis. Int Urol Nephrol;35(1):9-10, 2003.
22. Kilicarslan H, Gokce G, Ayan S, Guvenal T, Kaya K, Gultekin EY. Predictors of outcome after in situ anterior vaginal wall sling surgery. Int Urogynecol J Pelvic Floor Dysfunct ;14(5):339-41, 2003.
23. Kilicarslan H, Gokce G, Kaya K, Ayan S, Gultekin YE. Surgical treatment of penil fractures. Ulus Travma Derg.;9(1):54-6, 2003.
24. Yildiz E, Gokce G, Kilicarslan H, Ayan S, Goze F, Gultekin EY. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. BJU Int. 2004 ;93(7):1087-93.
25. Gokce G, Topsakal K, Ayan S, Kilicarslan H, Gokce SF, Gultekin EY. Case report: Nonobstructive giant urethral stone with two safety pins. Int Urol Nephrol. 2004;36(1):65-6.
26. Kaya K, Ayan S, Gokce G, Kılıcarslan H, Yildiz E, Gultekin EY. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma. Scand J Urol Nephrol. 38 :1-5,2004.
27. Ayan S, Kaya K, Topsakal K, Kılıçarslan H, Gokce G, Gültekin Y. Efficacy of tolterodine as a firstline treatment for non-neurogenic voiding dysfunction in children. BJU Int. 96(3):411-4, 2005.
28. Kaya K, Gokce G , Kaya S, Kilicarslan H, Ayan S, Gultekin EY. Isolated renal and retropertoneal hydatid cysts: a report of 23 cases. Trop Doct. 2006 Oct;36(4):243-6.
29. Candan F, Ayan S, Tas F, Gokce G, Elagoz S. Spontaneous renal laceration as the presenting feature of polyarteritis nodosa in a patient with familial Mediterranean fever after hepatitis A infection. Rheumatol Int, 25(6):475-7, 2005.
30. Silig Y, Pinarbasi H, Gunes S, Ayan S, Bagci H, Cetinkaya O. Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Cancer Invest, 24(1):41-5, 2006.
31. Tanzer F, Ozgur A, Bardakci F, Cankorkmaz L, Ayan S. Analysis of a 1-year-old cystinuric patient with recurrent renal stones. Int J Urol. 13(10):1347-9, 2006.
32. Kilicarslan H, Ayan S, Vuruskan H, Gokce G, Gultekin EY.Treatment of detrusor sphincter dyssynergia with baclofen and doxazosin. Int Urol Nephrol. 2006;38(3-4):537-41.
33. Ayan S, Topsakal K, Gokce G, Gultekin EY.Efficacy of combined anticholinergic treatment and behavioral modification as a first line treatment for nonneurogenic and nonanatomical voiding dysfunction in children: a randomized controlled trial. J Urol. 2007 Jun;177(6):2325-8; discussion 2328-9.
34. Ozdemir O, Gul E, Kilicarslan H, Gokce G, Beyaztas FY, Ayan S, Sezgin I.SRY and AZF gene variation in male infertility: a cytogenetic and molecular approach. Int Urol Nephrol. 2007;39(4):1183-9.
35. Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. BJU Int. 2008 Mar;101(6):758-64.
36. Kenan Kaygusuz, Gokhan Gokce, Iclal Ozdemir Kol, Semih Ayan and Sinan Gursoy. Efficacy of Preventive Analgesia with Tramadol or Lornoxicam for Percutaneous Nephrolithotomy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study. Current Therapeutic Research 68(4), 205-216, 2007.
37. Kaygusuz K, Gokce G, Gursoy S, Ayan S, Mimaroglu C, Gultekin Y.A comparison of sedation with dexmedetomidine or propofol during shockwave lithotripsy: a randomized controlled trial. Anesth Analg. 2008 Jan;106(1):114-9.
38. Gokce G, Karboga H, Yildiz E, Ayan S, Gultekin Y. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on apoptotic changes in contralateral testis following unilateral testicular torsion. Int Urol Nephrol. 2008;40(4):989-95.
39. Ozdemir, O (Ozdemir, Oztuerk); Yildiz, E (Yildiz, Esin); Ayan, S (Ayan, Semih); Gul, E (Gul, Eylem)1; Gokce, G (Gokce, Goekhan); Yildiz, F (Yildiz, Fazilet)1; Koksal, B (Koksal, Binnur)1; Goze, F (Goze, Fahrettin); Gultekin, EY (Gultekin, E. Yener). Epigenetic alterations and oncogenes mutations in urinary bladder carcinomas.CHROMOSOME RESEARCH. 2009, Volume: 17 Supplement: 1 Pages: 171-171
40. Eskicorapci SY, Türkeri L, Karabulut E, Cal C, Akpinar H, Baltaci S, Baykal K; Turkish Validation Study Group of Kattan Preoperative Nomogram, Kattan MW, Ozen H. Collaborators: Yildirim A, Yazici S, Divrik RT, Ozkardeş H, Koşan M, Kurtuluş FO, Büyükalpelli R, Mungan A, Lekili M, Sahin H, Günlüsoy B, Ayan S, Bozlu M. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Urooncology Society. Urology. 2009 Dec;74(6):1289-95.
41. Ozdemir O, Yildiz S, Ayan S, Gül E, Gokce G, Yildiz F, Koksal B. Promoter hypermethylation of tissue specific tumor supressor genes and point mutation in K-ras, c-myc proto-oncogenes in urinary (transitional cell) bladder carcinoma. Health. 2010; 2(8):850-856.
42. Türkeri L, Tanıdır Y, Çal Ç, Özen H, Şahin H; Collaborators :Kaya C, Karaman İ, Şengör F, Alkibay T, Sözen S, Büyükalpelli R, Can C, Kuyumcuoğlu U, Albayrak S, Abay E, Soyupak B, Tansuğ Z, Fazlıoğlu A, Gültekin Y, Ayan S, Gümüş E, Lekili M, Dillioğlugil Ö, Özer G, Uygur C, Akpınar H. Comparison of the efficacy of single or double intravesical epirubicin instillation in the early postoperative period to prevent recurrences in non-muscle-invasive urothelial carcinoma of the bladder: prospective, randomized multicenter study. Urol Int. 2010;85(3):261-5.
43. Kuzgunbay B, Yaycioglu O, Soyupak B, Atay Kayis A, Ayan S, Yavascaoglu I, Cal C, Beduk Y; Turkish Study Group of Public Awareness in Testicular Cancer Public awareness of testicular cancer and self-examination in Turkey: A multicenter study of Turkish Urooncology Society.Urol Oncol. 2011 Mar 22. Epub ahead of print]
44. Biçer H, Korgali E, Gökçe G, Ayan S, Yıldırım S, Gültekin EY. Contractile responses of urinary bladder in an experimental model of chronic renal failure. Bosn J Basic Med Sci. 2012 Nov;12(4):219- 23.
45. Yaycioglu O, Eskicorapci S, Karabulut E, Soyupak B, Gogus C, Divrik T, Turkeri L, Yazici S, Ozen H; Society of Urooncology Study Group for Kidney Cancer Prognosis. A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancer. Jpn J Clin Oncol. 2013 Jan;43(1):63-8.
46. Erden Y, Korgalı E, Dundar G, Ayan S, Gokce G, Yildirim S, Gultekin EY. In-vitro effects of PDE5 inhibitor and statin treatment on the contractile responses of experimental MetS rabbit's cavernous smooth muscle. Arch Ital Urol Androl. 2014 Mar 28;86(1):33-8.
Mali interdisciplinary hospital is integrating conventional, regenerative and precision medicine. It divides into 11 departments, there are 35 beds in total, including 12 intensive care beds, 23 general beds, 2 emergency and operating rooms, 1 plastic surgical room, 1 Gastro-colonoscopic room. Focus on round-trip treatment with modern medical technology to reduce the cost of hospitalization and the healing time. It also integrating regenerative medicine to repair the body and precision medicine for preventing and treating chronic non-communicable diseases (NCDs) with better results, we provide these services in a greenery atmosphere. Allowing clients to receive the following benefits.
1. Far away from NCDs & It’s complication
2. Good quality of life
3. Youthful lively life
4. Longevity